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Water-soluble peptide-chitosans were obtained by reaction of low-molecular-weight chitosan, having a low degree of acetylation,
with peptide substituents under mild conditions. These peptide substituents were prepared by standard peptide chemistry from 3-
bromopropanoic acid and tert-butyl esters of the a-amino acids glycine and phenylalanine. The structure of the new peptide-chito-
san polymers was confirmed by proton nuclear magnetic resonance and infrared spectroscopy. The thermotropic and morphological
properties of both the new peptide-chitosans and two other analogues, derived from valine and aspartic acid [synthesis reported in
Batista, M. K. S., Pinto, L. F., Gomes, C. A. R., & Gomes, P. (2006). Novel highly soluble peptide-chitosan polymers: Synthesis
and spectral characterization. Carbohydrate Polymers, 64, 299–305], were evaluated by differential scanning calorimetry and scanning
electron microscopy, respectively. As compared to the parent unmodified chitosan, the four peptide-chitosans had higher thermo-
sensitivity, porosity and water-holding capacity, and such effects increased with the hydrophilicity of the peptide ligands. The
acid-base properties of the four peptide-chitosans were also evaluated by potentiometric techniques and reflected the influence of
the inserted ligands on the polymers’ acidity constants. It was also possible to confirm the polymers’ solubility over the 2–10
pH range. Overall, these polymers present physico-chemical properties that make them promising candidates for the design of novel
drug delivery systems.
 2007 Elsevier Ltd. All rights reserved.
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Biodegradable polymers derived from renewable
resources have recently generated much interest for diverse
pharmaceutical applications, such as drug transport and
controlled release in vivo (Aiping, Jianhong, & Wenhui,
2006; Atyabi, Majzoob, Iman, Salehi, & Dorkoosh, 2005;
Lin et al., 2005; Liu, Hsu, Su, & Lai, 2005; Ruel-Garie´py
et al., 2004; Tapia et al., 2004; Thierry et al., 2005; Van
der Merwe, Verhoef, Kotze´, & Junginger, 2004). Chitosan0144-8617/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.carbpol.2007.05.015
* Corresponding author. Tel.: +351 226082863; fax: +351 226082959.
E-mail address: pgomes@fc.up.pt (P. Gomes).(CT), a copolymer of glucosamine and N-acetylglucos-
amine, is a non-toxic, biodegradable and biocompatible
material that has been used for several biomedical purposes
from gene therapy to suture and wound healing materials,
vascular grafts and cartilage regeneration, among many
others (Berger, Reist, Mayer, Felt, & Gurny, 2004; Berger
et al., 2004; Chandy & Sharma, 1992; Danielsen, Va˚rum, &
Stokke, 2004; Gupta & Ravikumar, 2000; Iwasaki et al.,
2004; Mansouri, Lavigne, Corsi, Benderdour, & Beau-
mont, 2004; Mi, Sung, & Shyu, 2002; Wong et al., 2006;
Zhu, Ming, & Jian, 2005). Some of the most appealing
characteristics of CT are its bioadhesive properties and
its ability to promote cell proliferation and, consequently,
tissue regeneration (Berger et al., 2004). These properties
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Scheme 1. Synthetic route to the peptide ligands: (i) DCCI or DIPCDI,
DCM, r.t. (ii) TFA, r.t.; R = amino acid side chain.
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of acetylation (Amaral, Lamghari, Sousa, Sampaio, &
Barbosa, 2005; Amaral, Sampaio, & Barbosa, 2005; Berger
et al., 2004) and are of outmost importance for biomedical
engineering. Further, owing to its particular structure and
self-assembly properties, CT has proved to be a useful
excipient in the pharmaceutical industry (Bernkop-
Schnu¨rch, 2000; Bernkop-Schnu¨rch & Kast, 2001; Janes,
Calvo, & Alonso, 2001; Krauland, Guggi, & Bernkop-
Schnu¨rch, 2006; Takeuchi et al., 2005). Notwithstanding,
the poor solubility of chitosan in both water and current
organic solvents limits its effective utilization in this field.
One of the reasons for the intractability of chitosan lies
in its rigid crystalline structure that is related with the acet-
amido and primary amino groups that induce relevant con-
formational features through intra- and/or intermolecular
hydrogen bonding (Nishimura, Kohgo, Kurita, & Kuzuha-
ra, 1991). Replacement of one, or both, primary amino
group’s hydrogens by other substituents, through suitable
chemical modifications, is a possible means for partial
destruction of its rigid crystalline structure, increasing the
polymer’s solubility in aqueous or organic media (Liu,
Desai, Chen, & Park, 2005). Numerous efforts have been
made to prepare functional and soluble derivatives of
chitosan (Delben, Gabrielli, Muzzarelli, & Stefancich,
1994; Kurita, Ikeda, Yoshida, Shimojoh, & Harata, 2002;
Muzzarelli, 1988; Muzzarelli, Tanfani, & Emanuelli,
1984; Skorik, Gomes, Vasconcelos, & Yatluk, 2003). Thus,
chemical modifications have been carried out on the chitin
and chitosan glucopyranoside ring, conferring to the new
materials surprising properties and additional possibilities
of engaging in a wide range of chemical reactions (Holappa
et al., 2004, 2005; Holappa, Nevalainen, Soininen, Ma´sson,
& Ja¨rvinen, 2006).
We are devoted to the development of different strate-
gies for in vivo transport and controlled release of drugs
that are prone to be rapidly inactivated in the first-pass
metabolism (Arau´jo et al., 2005; Chambel et al., 2006;
Gomes et al., 2004; Santos et al., 2005). The development
of chitosan-based materials as potential vehicles for those
drugs is one of such strategies. So, new water-soluble chito-
san derivatives have been previously prepared in our
group, namely, several N-(2-carboxyethyl)-chitosans
(Skorik et al., 2003), and two peptide-chitosans (PC),
N-(c-propanoyl-valin)-chitosan and N-(c-propanoyl-aspar-
tic acid)-chitosan (Batista, Pinto, Gomes, & Gomes, 2006).
The potential applications of these polymers as antioxidant
and antimutagenic agents (Kogan et al., 2004) as well as
metal chelating agents (Skorik et al., 2005) have also been
studied. The present paper describes the preparation and
structural characterization of two additional PC deriva-
tives, N-(c-propanoyl-glycine)-chitosan and N-(c-propa-
noyl-phenylalanine)-chitosan, which were thoroughly
characterized together with the two PC previously reported
(Batista et al., 2006) to assess their physico-chemical prop-
erties and conclude about their potential interest for drug
delivery in vivo.2. Experimental
2.1. Materials
Low molecular weight (MW  150 kDa) chitosan from
coarse ground crab (Ref. 44.886-9, Aldrich) was used, hav-
ing a 10% degree of acetylation (DA = 10%) as determined
by 1H NMR and 5.4 mmol N/g as determined by elemental
analysis, i.e., 4.86 mmol of free –NH2 groups per gram of
polymer. 3-Bromopropanoic acid, N,N 0-dicyclohexylcar-
bodiimide (DCCI), N,N 0-diisopropylcarbodiimide (DIP-
CDI), CDCl3, D2O, DCl, anhydrous trifluoroacetic acid
(TFA) and common organic solvents (p.a. quality) were
all from Sigma–Aldrich. Glycine-, L-phenylalanine-,
L-valine-tert-butyl ester hydrochlorides, and L-aspartic acid
b-tert-butyl a-tert-butyl diester hydrochloride, were all
from Bachem (Switzerland). Thin layer chromatography
(TLC) plates (aluminium foil covered with 0.25 mm thick
silica gel 60, F254) were from Merck (Germany), and silica
gel for column chromatography (Chromagel, pH 7, 35–
70 lm, 550 m2/g) was from SDS (France).2.2. Synthesis
2.2.1. Peptide ligands
The peptide ligands were prepared as previously
described (Batista et al., 2006), by condensation (Scheme
1) of 3-bromopropanoic acid with the tert-butyl esters of
glycine or L-phenylalanine, by the carbodiimide (DCCI or
DIPCDI) method (Gomes et al., 2004). Briefly, the relevant
amino acid tert-butyl esters, purchased as hydrochloride
salts, were obtained as free amines (free a-amino group)
after neutralization of the hydrochloride (29.5 mmol) with
aqueous Na2CO3 at 30% until pH 11, followed by extrac-
tion with 5 · 20-mL dichloromethane (DCM), pooling of
the organic layers, drying over anhydrous MgSO4 and
evaporating to dryness. The L-amino acid tert-butyl esters
were thus isolated as yellow oils with yields range between
72% and 92%. These compounds were dissolved in DCM
(100 mL), then 3-bromopropanoic acid (29.5 mmol) was
added and the solution was stirred in an ice-water bath
for 30 min. Then, a suitable carbodiimide (DCCI or
56 P. Gomes et al. / Carbohydrate Polymers 71 (2008) 54–65DIPCDI, 32.5 mol) in 10% excess was slowly added to
solution, which was kept at 0 C for more 2 h. The reaction
was allowed to proceed at room temperature for 48 h, with
periodic monitoring by TLC. The solid phase formed was
removed by suction filtration and identified as the carbodii-
mide-derived urea (DCU or DIU). The filtrate was evapo-
rated to dryness and the oily residue dissolved in the
minimum amount of warm acetone; the resulting solution
was stored overnight at 4 C and the additional urea pre-
cipitate was again removed by suction filtration. The fil-
trate was evaporated to dryness and the residue
submitted to column chromatography on silica-gel, using
20:1 (v/v) DCM/acetone as eluant. The Na-(3-bromoprop-
anoyl)amino acid tert-butyl esters were isolated as yellow
oils in 50–78% yields and their structure confirmed by 1H
and 13C NMR. These esters were then dissolved in a small
volume of neat TFA (10 mL) and the reaction was allowed
to proceed for 24 h at room temperature. Excess TFA was
evaporated and the free carboxylic acids were precipitated
in ethyl ether as white solids and their structures were also
confirmed by 1H and 13C NMR. Spectroscopic data for the
four peptide ligands and their tert-butyl ester precursors
are supplied as supporting information.2.2.2. Peptide-chitosan (PC) derivatives
Chitosan (0.9 g, 4.4 mmol of free –NH2) was added
portion-wise, over 1 h, to an aqueous solution (20 mL) con-
taining four molar equivalents of the Na-(3-bromopropa-
noyl)-amino acid ligand, as previously described (Batista
et al., 2006; Scheme 2). When necessary, the insoluble frac-
tion was separated by filtration. An equivalent amount of
NaHCO3 was added portion-wise to the chitosan/peptide
solution, which was stirred for additional 30 min to remove
the excess of CO2 (pH 6.5). After stirring at 60 C for 6 h,
NaHCO3 (1 g) was added (pH 8.5) and stirring was contin-
ued until the reaction was seen to have no further evolution
(constant pH). Polymer precipitation with ethanol was
done to separate the polymeric product from the excess
of low-molecular-weight reactants. The precipitate was fil-
tered and dissolved in water, acidified to pH 1–2 with con-
centrated HCl, dialyzed against deionized water over 2–3O
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Scheme 2. Synthesis of the peptide-chitosans, (i) NaHdays (Spectra/Por dialysis tube membrane, MW cut-off
1 kDa, No. 132638) and freeze-dried (Christ alpha 1–4
freeze-drier) prior to further studies, detailed below.2.2.3. Infrared spectroscopy (FTIR)
FTIR spectra of KBr pellets of chitosan and PC deriva-
tives were recorded on a Jasco FT/IR-460 instrument. All
spectra were acquired from 32 scans between 4000 and
400 cm1 at a resolution of 4 cm1 and were run in
duplicate.2.2.4. Nuclear magnetic resonance (NMR)
NMR spectra were recorded on a Bruker AMX 300
spectrometer. Peptide ligands and their ester precursors
were dissolved in DMSO-d6 and CDCl3, respectively, to
which tetramethylsilane (TMS) was added as internal refer-
ence. Chitosan was dissolved in DCl/D2O 1:100 (v/v) and
the PC derivatives in DCl/D2O 1:1 (v/v), and 3-(trimethyl-
silyl)-1-propanesulfonic acid (DSS) was added to all poly-
mer solutions as internal standard for 1H NMR chemical
shifts. The 1H NMR spectra of the polymers were recorded
at 70 C for signal resolution improvement.2.2.5. Potentiometric titrations (PT)
All titrations were performed in duplicate in the 2–10 pH
range, with a high precision titration system and the same
general conditions previously described (Skorik et al.,
2003, 2005). A solution of each sample of the PC derivatives
(1.7 mmol L1 of amino groups), arbitrarily represented as
Glc-HNR, was prepared by dissolving a prescribed amount
of the polymer with a known volume of 0.1000 mol L1
HNO3 necessary to achieve complete protonation of the
PC polymers. After ionic strength adjustment with
0.1 mol L1 KNO3, the titration was conducted with a car-
bonate-free (Albert & Sergeant, 1971) 0.1 mol L1 KOH
standardized just before each titration. The glass electrode
was calibrated in terms of hydrogen ion concentration by
using buffers in the pH range 4–9 with ionic strengths
adjusted to 0.1 with KNO3 (Vasconcelos & Machado,
1986). The acid-base parameters were calculated and refinedO
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Fig. 1. FTIR spectra (KBr pellets) of (A) Chitosan; (B) N-(c-propanoyl-
glycine)-chitosan and (C) N-(c-propanoyl-phenylalanine)-chitosan.
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2.2.6. Differential scanning calorimetry (DSC)
The thermal behavior of chitosan and PC derivatives was
determined byDSC. The samples were stored for 72 h under
low humidity conditions, i.e., on a vacuum desiccator over
silica-gel, prior to thermal analysis. A NETZSCH – DSC
204 calorimeter, equipped with a controlled TASC 414/3A
were used. Samples (1–2 mg; Mettler M3 Microbalance)
were scanned in crimped sealed aluminium pans under
nitrogen atmosphere (20 mL min1). An empty pan was
used as reference. The temperature interval used was
30–500 C scanned at 10 C/min.
2.2.7. Scanning electron microscopy (SEM)
The surface morphologies of chitosan (CT), freeze-dried
chitosan (FdCT) and peptide chitosan (PC) derivatives
were examined by SEM. The samples were sputtered-
coated with gold (10–20 nm thick; JEOL JFC 1100) and
observed using a JEOL JSM-6301F scanning electron
microscope.
3. Results
3.1. Infrared spectroscopy
FTIR was employed to examine the structural changes
caused by insertion of peptide ligands into the parent chito-
san polymer. The IR spectrum of chitosan is characterized
by: large and intense bands at 3450–3200 cm1 (hydrogen-
bonded O–H stretching overlapped with the several N–H
stretching bands); C–H stretching at 2783 cm1; bands
due to the GlcNHAc units, with amide I (C@O stretching)
at 1650 cm1, amide II (N–H bending) at 1565 cm1,
amide III (C–N stretching coupled with N–H plane
deformation) at 1412 cm1 and symmetrical angular
deformation of –CH3 at 1376 cm
1; C–N stretching of
the amino groups at 1325 cm1; O–H plane deformation
at 1262 cm1; C–O–C stretching vibration in the glucopyr-
anose ring at 1028 cm1; and the specific bands of the
b(1fi 4) glycoside bridge at 1153 and 895 cm1 (Mansouri
et al., 2004; Tian, Liu, Hu, & Zhao, 2004).
In comparison with the chitosan FTIR spectrum, N-(c-
propanoyl-glycine)-chitosan and N-(c-propanoyl-phenylal-
anine)-chitosan spectra showed new absorption peaks at
1738 and 1736 cm1, respectively (Fig. 1, encircled peaks),
corresponding to the C@O stretching mode of the
carboxyl-functionalized ligands. These bands were also
present in the FTIR spectra of the peptide-chitosans
previously reported and unmistakably confirm the
insertion of the peptide ligands (Batista et al., 2006). The
analysis of the amide I, amide II and amide III regions is
not straightforward for the PCs; bands due to the amide
of GlcNHAc will be overlapped to those due to the amide
bond from the peptide ligand and, further, to bands arising
from ionized groups, namely, –COO stretching and–NH3
þ bending (Lin et al., 2005), turning unequivocal
band attribution in this region a virtually impossible task.
Nonetheless, as PC polymer’s DA (10%) are smaller than
their degree of substitution (DS), as determined by 1H
NMR (cf Section 3.2), spectral characteristics in the amide
I–amide III region will be mainly determined by the peptide
ligand rather than by the GluNHAc units. Thus, differ-
ences are to be expected in this region when comparing
FTIR spectra of the PC with the spectrum of unmodified
chitosan. In fact, a clear shift of transmittance minima to
lower wavenumbers in the amide I, II and III regions
(Liu, Du, Yang, & Zhu, 2004; Peniche et al., 1999) is
observed for both N-(c-propanoyl-glycine)-chitosan and
N-(c-propanoyl-phenylalanine)-chitosan, respectively, as
follows: amide I, 1620 and 1616 cm1; amide II, 1546
and 1544 cm1; amide III, 1395 and 1383 cm1. This,
again, shows that peptide ligands were inserted into the
chitosan matrix.3.2. 1H NMR spectroscopy
Chemical structure of the PC polymers was determined
by 1H NMR spectroscopy. The 1H NMR spectra of the
modified chitosans are displayed in Fig. 2A (N-(c-propa-
noyl-glycine)-chitosan) and B (N-(c-propanoyl-phenylala-
nine)-chitosan) and the corresponding spectral data are
given below. Fig. 2A shows signals at 4.56, 4.80 and 4.92
that were assigned to the H-1 hydrogen from acetylated,
unsubstituted and monosubstituted units of D-glucosa-
mine, respectively. Similarly, Fig. 2B shows overlapping
signals from 4.99 to 5.19 that were assigned to the H-1
hydrogen from acetylated, unsubstituted and monosubsti-
tuted D-glucosamine units. An identical pattern was
previously noted in our work on N-(c-propanoyl-valin)-
chitosan and N-(c-propanoyl-aspartic acid)-chitosan
(Batista et al., 2006). These results confirm the effective
insertion of the peptide ligands in the chitosan biopolymer,
corroborating the FTIR analysis above discussed.
Peaks attributed to reducing end protons of H-1 (Ishig-
uro, Yoshie, Sakurai, & Inoue, 1992) were observed at 5.14
and 5.34 ppm for (N-(c-propanoyl-glycine)-chitosan) and
ppm
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Fig. 2. 1H NMR spectra (D2O/DCl 1:1 v/v, 70 C, 300 MHz) of (A) N-(c-
propanoyl-glycine)-chitosan and (B) N-(c-propanoyl-phenylalanine)-
chitosan.
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chitosan), suggesting that some degree of polymer hydroly-
sis occurred in the course of the NMR experiments. This
interpretation is supported by a previous work from
Va˚rum et al., who thoroughly studied the acid hydrolysis
of chitosans by evaluating the influence of several factors
on the rate and selectivity of hydrolysis of chitosans in
the presence of hydrochloric acid (Va˚rum, Ottøy, &
Smidsrød, 2001). These authors observed that the rate of
de-N-acetylation was similar to the rate of hydrolysis of
the glycosidic linkage in dilute acid, whereas the glycosidic
linkages hydrolyzed ca. 10 times faster than de-N-acetyla-
tion in concentrated HCl (12.08 M). Also, different hydro-
lysis rates were measured for the four different glycosidic
linkages, A–A, A–D, D–A and D–D, where A stands for
a GlcNHAc and D for a GlcNH2 unit. The first two types
hydrolyzed at virtually the same rate but at about three
times faster than the latter two. Finally, hydrolysis rates
markedly increased with HCl concentration, time,
temperature and polymer’s DA. Overall, the findings from
Va˚rum et al. (Va˚rum et al., 2001) explain our observations,
as our samples were dissolved in DCl at 6 M in D2O and
spectra were acquired at high temperature (70 C) over
extended periods of time (P6 h). Polymer hydrolysis could
be minimized by running the NMR experiments at lower
DCl concentration, lower temperature and/or shorter
acquisition times, but attempts to run the NMR experi-ments in such a way failed to yield spectra with adequate
quality (poor signal resolution and/or overlapping of rele-
vant peaks with the D2O signal were observed).
NMR peak integrals allowed us to determine the DA
and DS for each PC polymer. Taking v as the sum of the
integrals measured for peaks of H-1 from GlcNHAc,
GlcNH2 and GlcNHR units in each polymer (Fig. 2),
DA was calculated as the quotient between 1/3 the integral
of the –CH3 peak at 2.13 ppm (Fig. 2A) or 2.50 ppm
(Fig. 2B) and the value of v for the corresponding polymer.
DA was found to be 10% for both polymers, matching
the value of the commercial chitosan used. Therefore, reac-
tion conditions for the insertion of the peptide ligands were
mild enough to keep the polymer’s DA unchanged, as
expected. The DS value for N-(c-propanoyl-glycine)-chito-
san was calculated as the quotient between the integral
measured for the peak of H-1 from GlcNHR (4.92 ppm,
Fig. 2A) and the v sum obtained for this polymer. How-
ever, in the case of N-(c-propanoyl-phenylalanine)-chito-
san, the peak of H-1 from GlcNHR was not resolved, so
the integral of the phenylalanine a-CH proton or 1/5 the
integral of the phenylalanine aromatic protons (Fig. 2B)
were used instead. DS values of 26% and 12% were thus
obtained for N-(c-propanoyl-glycine)-chitosan and N-(c-
propanoyl-phenylalanine)-chitosan, respectively, the first
one comparing well with the DS values of 32% and 27%
previously found for N-(c-propanoyl-valin)-chitosan and
N-(c-propanoyl-aspartic acid)-chitosan, respectively
(Batista et al., 2006). However, the DS value for the phen-
ylalanine-based polymer (12%) is significantly lower than
those for the other three PC polymers (averaged to 28%).
This can be attributed to a combination of two factors,
namely, (i) the observed low solubility of Na-(3-bromo-
propanoyl)-phenylalanine in the aqueous reaction medium,
and (ii) influence of the bulky amino acid side chain (benzyl
group) on reactivity. However, the point at which the four
a-amino acids differ from each other (i.e., their side chains)
is five bonds apart from the terminal bromo-methylene
group where the SN2 occurs, so the amino acid side chain
is expected to have only little influence on reactivity. Thus,
solubility problems seem to be the main cause for the low
DS obtained for N-(c-propanoyl-phenylalanine)-chitosan.
Not taking into account this particular case, we may say
that, under the conditions employed, the average yield
for the insertion of Na-(3-bromopropanoyl)-amino acid
ligands into the chitosan polymeric chain is of 30%.
3.2.1. N-(c-Propanoyl-glycine)-chitosan (Fig. 2A)
dH/ppm (D2O/DCl 1:1 v/v, 70 C, 300 MHz): 2.13–2.23
(m, 0.33 H, –CH3 of GlcNHAc from polymer + hydro-
lyzed units), 2.76 (m, 0.52H, –CH2CH2CONH– from
GlcNHR), 3.13 (m, 0.95H, H-2 from GlcNHR and
GlcNH2), 3.35–4.10 (m, 6.01H, H-2 from GlcNHAc,
–CH2CH2CONHCH2COOH from GlcNHR and H-3,4,5,
6a and 6b from GlcNH2, GlcNHR and GlcNHAc), 4.56
(d, 0.10H, H-1 of GlcNHAc), 4.80 (d, 0.60H, H-1 from
GlcNH2), 4.92 (d, 0.24H, H-1 from GlcNHR), 5.14 (d,
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Model 33.2.2. N-(c-Propanoyl-phenylalanine)-chitosan (Fig. 2B)
dH/ppm (D2O/DCl 1:1 v/v, 70 C, 300 MHz): 2.52 (m,
0.30H, –CH3 from GlcNHAc), 2.85 (m, 0.25H,
–CH2CH2CONH– from GlcNHR), 3.06 (m, 0.25H,
–CH2Ph from GlcNHR), 3.37–4.30 (m, 6.02H, H-2 from
GlcNHR and GlcNH2, –CH2CH2CONH– from GlcNHR
and H-3,4,5,6, from GlcNH2, GlcNHR and GlcNHAc),
4.51 (t, 0,12H,–CHCH2Ph), 4.74 (t, 0.10H, H-2 from Glc-
NHAc), 4.99–5.19 (m, 0.83H, H-1 from GlcNHAc,
GlcNH2 and GlcNHR), 5.40 (d, 0.12H, H-1 from GlcNH2
hydrolyzed unit), 5.59 (d, 0.05H from GlcNHR hydrolyzed
unit), 7.39 (m, 0.62H, H phenyl group of GlcNHR).
Finally, the knowledge of the DS values of all PC poly-
mers, as deduced from 1H NMR data, provides a means to
estimate the MWs of the four polymers. The commercial
chitosan used has a MW of 150 kDa and DA=10%, which
means that it is composed by 90% GlcNH2 units (MW =
161.16 Da) and 10% GlcNHAc units (MW = 203.19 Da).
Thus, the parent polymer combines 819 GlcNH2 mono-
mers with 91 GlcNHAc units. The PCs prepared have a
percentage of the 819 GlcNH2 units equal to the polymer’s
DS where the –NH2 groups are replaced by the corre-
sponding –NHR. Simple calculations, using the polymers’
DS values and the MWs of the different R ligands, allow
us to estimate the following MWs for the PC polymers:
N-(c-propanoyl-glycine)-chitosan, 185 kDa; N-(c-propa-
noyl-phenylalanine)-chitosan, 176 kDa; N-(c-propanoyl-
valin)-chitosan, 205 kDa; N-(c-propanoyl-aspartic acid)-
chitosan, 201 kDa. As expected, peptide ligand insertion
increased the global MW of the polymers, as compared to
unmodified chitosan, by 17–34%. These increments reflect
both the MW of the peptide ligands and the DS attained
under the reaction conditions employed. Therefore, higher
MW increments should be expected for longer reaction
times or greater molar excesses of the peptide ligand, as a
consequence of the higher DS that would be theoretically
reached. However, we have observed that, using four molar
equivalents of the peptide ligand, the reaction did not fur-
ther progress after 6 h, so longer reaction times would
hardly lead to increased DS. Thus, higherMWs would most
probably be reached only by increasing the molar excess of
the peptide ligand used in the reaction, as harsher reaction
conditions should be avoided. Anyway, a maximum ligand
insertion level would most probably be reached, so much
greater increments of final polymer’s MW are probably dif-
ficult to attain.Val
Fig. 3. Statistical parameter, r, for the refinement (Hyperquad) of PC
titration curves using Models 1–3 to describe the acid-base system.3.3. Potentiometric studies
Potentiometric titrations of fully protonated PC and CT
polymers were carried out by addition of carbonate-free
KOH solution to the polymer aqueous solutions. All PC
polymers were completely soluble in the 2–10 pH range,as visually checked in the course of the titrations. Even
though visual inspection may be considered as not enough
accurate to be used as a tool for solubility evaluation, the
fact is that, in the course of identical potentiometric titra-
tions on unmodified chitosan solutions, turbidity is
observed when the pH is reaching 6 and, when pH reaches
6.5, polymer precipitation starts to occur. None of these
phenomena were seen for the PC polymers, and that is
enough prove that, at the macroscopic level, peptide-chito-
sans are significantly more water-soluble than the parent
chitosan over the entire pH range used in the titrations.
This is even more remarkable if we take into account that
the new PC polymers have slightly higher MW (averaged to
192 kDa) than the parent chitosan (150 kDa), as higher
MWs would contribute to a decreased solubility in aqueous
media.
In order to accurately determine the acidity constants of
the polymers, three models were taken into account:Model
1 – The polymer was considered as a diprotic species,
whose concentration is the same of the ionisable amino
groups. Model 2 – Amino and carboxylic groups were trea-
ted as two independent monoprotic species and the concen-
tration of the carboxylic groups considers the DS. Model 3
– Same as Model 2, but the amino groups were separated
into primary and secondary amino groups and treated as
two independent monoprotic species. Together with the
carboxylic groups, they compose a system with three
monoprotic species. The results obtained by fitting the
experimental data to each of the three models allowed us
to conclude that the best fits (Hyperquad r statistical
parameter – Fig. 3) were obtained withModel 3, suggesting
that this model describes a more realistic picture of the
ongoing acid-base phenomena. Indeed, curve-fitting with
Model 3 yielded two distinct pKa values related to basic
groups (Table 1), which reflects the presence of primary
and secondary amines, as the latter usually have higher
pKa values than the former. Table 1 shows that pK
H
1 values
Table 1
pKa values obtained by fitting experimental data to Model 3
Polymers PESH
 logKH1  logKH2  logKH3
Chitosan 6.40 ± 0.01 – –
N-(c-Propanoyl-glycine)-
chitosan
6.08 ± 0.01 7.42 ± 0.03 3.03 ± 0.04
N-(c-Propanoyl-phenylalanine)-
chitosan
6.12 ± 0.01 7.68 ± 0.07 2.7 ± 0.1
N-(c-Propanoyl-valine)-
chitosan
6.13 ± 0.04 7.26 ± 0.08 3.68 ± 0.05
N-(c-Propanoyl-aspartic acid)-
chitosan
5.80 ± 0.01 7.2 ± 0.2 2.3 ± 0.2
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pare well with the pKH1 value for chitosan (6.40) that has
only primary amino groups. Moreover, the PC’s pKH2 val-
ues, attributed to the ionization of the secondary amines,
vary in the 7.2–7.68 range, thus being higher than the cor-
responding pKH1 , as expected. The distinctive acid-base
properties displayed by chitosan and the four PC polymers
constitute an additional indirect proof of successful peptide
ligand insertion into the polymer matrix and provide a
means for the fine-tuning of pH-related properties of these
new materials. Again, the most obvious advantage of our
PC polymers is their solubility in aqueous medium over a
wide pH-range (at least, from pH 2 to pH 10), in clear con-
trast with chitosan that is only highly soluble in acidic
media (pH 6 6).3.4. Differential scanning calorimetry
DSC thermograms of chitin (CH), CT and FdCT
(Fig. 4A–C) exhibit an endothermic peak around 73, 100
and 87.3 C, respectively, attributed to the thermal evapo-
ration of bound water that could not be removed com-
pletely upon drying (Elizabeth & Pillai, 2006), which30 90 150 210 270 330 390 450
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Fig. 4. DSC thermograms of (A) chitin, (B) chitosan, (C) freeze-dried
chitosan.constitutes the polymer’s water holding capacity (WHC)
(Kittur, Prashanth, Sankar, & Tharanathan, 2002; Prash-
anth, Kittur, & Tharanathan, 2002; Rueda, Secall, &
Bayer, 1999; Tirkistani, 1998). Water is essentially bound
through the –OH and free –NH2 hydrophilic groups of
chitosan (Sato et al., 1997). The endothermic peak of
FdCT presents a shift towards a lower temperature rela-
tively to CT. This can be explained considering that the
process of solubilization followed by freeze-drying of chito-
san alters its supramolecular structure, simplifying the
polymer’s hydrogen bond network. The endothermic peak
of CH appears at the lowest temperature, as water is essen-
tially adsorbed to the CH surface. The endothermic peak
areas follow the order FdCT (DH = 648.4 J/g) > CT
(DH = 322.7 J/g) > CH (DH = 171.58 J/g), reinforcing
the existence of a correlation between the chemical and
supramolecular structure of the polymers and their WHC
(Kittur et al., 2002). So, these differences can again be
explained by the fact that FdCT can have additional free
–OH and –NH2 groups, previously engaged in inter-chain
hydrogen bonds, available for hydrogen-bonding to more
water molecules. Further, FdCT is not as compact as CT,
thus its increased area can hold more surface-adsorbed
water.
The second thermal event is an exothermic peak at 397,
307 and 292 C, respectively, for CH, CT and FdCT, and
can be attributed to the thermal degradation of these poly-
mers (Qin et al., 2003). The exothermic peaks of CH, CT
and FdCT also present a progressive shift towards lower
temperatures, which can also be explained by a progressive
weakening of the polymer supramolecular structure that
becomes increasingly thermo-sensitive.
In the case of the peptide-chitosan polymers (Fig. 5A–
D), the endothermic peaks were displaced to lower temper-
atures relatively to CT, appearing between 77 and 90 C.
The same behavior was observed for the exothermic peaks,30 90 150 210 270 330 390
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Fig. 5. DSC thermograms of (A) N-(c-propanoyl-valin)-chitosan, (B) N-
(c-propanoyl-aspartic acid)-chitosan, (C) N-(c-propanoyl-glycine)-chito-
san and (D) N-(c-propanoyl-phenylalanine)-chitosan.
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This downward shift of both the endothermic and exother-
mic peaks indicates that a significant change in the chemi-
cal and supramolecular structure of chitosan occurs when
additional functional groups are grafted onto the poly-
meric matrix. The peptide ligands thus seem to increase
the polymer’s WHC through the insertion of additional
amide and carboxyl groups.
Based on the area of the endothermic peaks, we found
that B (DH = 389.6 J/g) > C (DH = 273.6 J/g) > D (DH
= 248.0 J/g) > A (DH = 218.9 J/g) (Fig. 5), following the
decrease in hydrophilic character of the ligand –R (Scheme
2), which can be associated with a relative decrease in the
polymer’s WHC. Insertion of the Asp-based ligand into
the polymer matrix (curve B) induces a much more dra-
matic effect on DH values for the endothermic transition
than do the ligands based on the other three amino acids.
This can be ascribed to the fact that Asp was the only
tri-functional amino acid used, i.e., the only one with a
functional group in its side chain, namely, a carboxyl
group. The presence of two carboxyl groups in the
Asp-based ligand has two implications: (i) this ligand is
much more hydrophilic than the other three, and (ii) repul-
sion between carboxylates weakens the polymer supramo-
lecular structure to a much higher extent. As to the
temperatures at which the endothermic event happens, these
follow the order A (Tmax = 90.8 C) > B (Tmax = 85.9 C) >
D (Tmax = 79.0 C) > C (Tmax = 76.8 C). So, there seems to
be no obvious correlation between the temperature of the
endothermic transition with either ligand size or hydrophilic
character.
Looking at the exothermic peaks on the thermograms
of the PC polymers, three of them degraded at lower tem-
peratures than FdCT, but a marked exothermic peak was
not observable for the glycine-based polymer (curve C),
and an accurate determination of thermo-degradation
parameters for this PC was not possible. The thermo-deg-
radation temperatures are similar between the other three
PC, but the polymer’s thermo-sensitivity seems to be cor-
related with the ligand’s hydrophilic character: A (Tmax =
255.0 C) > D (Tmax = 252.5 C) > B (Tmax = 250.0 C).
Consequently, a significant perturbation of the naturally
strong and ordered structure of chitosan is caused by
insertion of the peptide ligands, yielding more thermo-
sensitive derivatives whose stability seems to decrease with
the increasing hydrophilic character of the ligand. Again,
we think that the two carboxyl groups from the Asp-
based ligand contribute to the weakening of the polymeric
structure both due to a higher capacity to bind water and
to a stronger repulsion between the negatively-charged
carboxylates. Our results agree with observations from
other authors (Elizabeth & Pillai, 2006; Gocho, Shimizu,
Tanioka, Chou, & Nakajima, 2000; Kittur et al., 2002;
Sarmento, Ferreira, Veiga, & Ribeiro, 2006), reinforcing
that grafting of hydrophobic or hydrophilic ligands to
chitosan results in a decrease of polymer crystallinity
by: (i) loosening the intra- and inter-chain hydrogenbonds that characterize the rigid polymer matrix, and
(ii) increasing the number of free hydroxyl and amino
groups available to bind water molecules. This leads to
increased WHC and thermo-sensitivity, as observed in
our case for the PC polymers. The second event on the
thermograms of our PC polymers can also be interpreted
according to what has been suggested by Kittur et al.
(2002) and Sarmento et al. (2006), who considered this
event as the association of two peaks: a smaller endother-
mic peak corresponding to the loss of crystallization water
strongly bound to the closely-packed polymeric structure,
immediately followed by a larger exothermic peak due to
polymer-degradation, i.e., de-polymerization and degrada-
tion of side chains and substituents (Britto & Campana-
Filho, 2004). In our case, the second event can also be
seen as a superposition of two peaks, which becomes
clearer for PC polymers (Fig. 5B and D).
3.5. Scanning electron microscopy
SEM micrographs show that the freeze-drying process
causes a significant change in the chitosan structure
(Fig. 6A and B). Commercial chitosan (CT, Fig. 6A) is a
powder that shows a compact morphology under the
SEM, whereas, after freeze-drying (FdCT, Fig. 6B), it
adopts a stripped film-like aspect. The morphology of
FdCT is similar to those presented by the peptide deriva-
tives (Fig. 6C–F). However, these have a more irregular,
sponge-like, surface, especially in the cases of N-(c-propa-
noyl-aspartic acid)-chitosan (Fig. 6D and insert) and N-
(c-propanoyl-phenylalanine)-chitosan (Fig. 6F and insert).
Once again, and in agreement with our observations in
DSC experiments, both freeze-drying and peptide ligand-
insertion lead to de-compacting of the polymeric matrices
and, in the case of PC polymers, to some quite surprising
morphologies that resemble either bone-like or honey-
comb-like structures. These highly porous structures may
become particularly interesting for potential biomedical
applications of these PC polymers.
4. Discussion
Chitosan is a non-toxic and soft-tissue compatible poly-
mer with a special ability to adhere to mucosal surfaces and
to transiently open the junctions between epithelial cells
(Artursson, Lindmark, Davis, & Illum, 1994; Kotze´
et al., 1999). There are several potential biomedical appli-
cations for low molecular weight chitosans, but many of
them are limited by the polymer’s low solubility above
pH  6. Effectively, chitosan is soluble in the stomach
acidic conditions but precipitates in the intestinal tract,
so it is only residually absorbed in the intestine. This char-
acteristic has been exploited for the development of chito-
san-based ‘‘fat-trappers’’ as weight reducers: in the
stomach, fat is emulsified by dissolved chitosan, after
which the chitosan-fat emulsion precipitates upon arrival
to the intestine, from which it is excreted. Still, the limited
Fig. 6. SEM photographs (200· magnification) of (A) chitosan (CT), (B) lyophilised chitosan (FdCT), (C) N-(c-propanoyl-valin)-chitosan, (D) N-(c-
propanoyl-aspartic acid)-chitosan (insert: 1000· magnification), (E) N-(c-propanoyl-glycine)-chitosan and (F) N-(c-propanoyl-phenylalanine)-chitosan
(insert: 2500· magnification).
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peutic applications. Having the purpose of overcoming this
obstacle, we have successfully prepared chitosan deriva-
tives through covalent binding, to the polymer’s amino
groups, of peptide ligands obtained by condensation of 3-
bromopropanoic acid with natural a-amino acids. These
new polymers possess positively (primary amino) and neg-
atively (carboxyl) charged groups and are fully water-solu-
ble in the physiological pH range. This is a major
advantage for chitosan-based vehicles for oral drug admin-
istration as, for instance, Thanou et al. have found that N-
trimethylchitosan chloride is water-soluble in the entire pH
range and acts as an absorption enhancer for oral peptide
drug delivery by facilitating the paracellular peptide trans-
port (Thanou, Florea, Langemey¨er, Verhoef, & Junginger,
2000; Thanou, Verhoef, Marbach, & Junginger, 2000; Tha-
nou, Verhoef, Verheijden, & Junginger, 2001; Thanou
et al., 1999; Van der Merwe et al., 2004). Other examples,
where combination of opposite charges combined in chito-
san-based materials leads to interesting drug delivery prop-
erties, have been described by Tapia et al. (2004), who
reported chitosan-alginate complexes as prolonged drug
release systems, by Thierry et al. (2005), who developed a
polyelectrolyte multilayered platform for the administra-
tion of paclitaxel, and by Ruel-Garie´py et al. (2004), who
showed that a thermo-sensitive chitosan/b-glycerophos-
phate hydrogel may have an important role for the local
delivery of paclitaxel. Also, Lin et al. (2005) reported chito-
san and poly-c-glutamic acid co-polymeric nanoparticles
with enhanced intestinal paracellular transport properties.
This enhancement can be attributed to the carboxylates
from the poly-c-glutamic acid, as they partially cancel the
cationic character of chitosan, yielding a more zwitterionic
material, thus with extended water-solubility over a wider
pH range. In view of all this, it is reasonable to expect that
our new peptide-chitosans can act as enhancers for oraldrug absorption through the paracellular pathway, and
such will be perhaps more pronounced for the Asp-derived
polymer that has higher carboxylate content. Further, our
peptide-chitosans are expected to be more stable under
physiological conditions than the above mentioned co-
polymers, as the anionic portion in our case is covalently
attached to chitosan.
Variation of reaction time and/or stoichiometry in
ligand insertion can be used to produce different degrees
of substitution, i.e. different NH3
þ=COO ratios,
according to specific needs for each particular case. The
ammonium groups are important for electrostatic immobi-
lization of anionic drugs and account for the bioadhesive,
bacteriostatic and blood cell affinity properties of chito-
san-based hydrogels (Amaral et al., 2005; Liao, Lin, &
Wu, 2005). On the other hand, the presence of carboxyl
groups in the same polymer not only provides a means
for the electrostatic immobilization of cationic drugs, but
also promotes a reversible and pH-dependent ionic cross-
linking of the matrix that is desirable over irreversible
covalent cross-linking of hydrogels for biomedical applica-
tions (Berger et al., 2004).
The insertion of carboxyl groups into the chitosan
matrix has also the important advantage of providing
an additional functionality that can be used for different
purposes. Thus, these peptide-chitosans offer the possibil-
ity of making use of alcohol, amine and carboxylic acid
chemistries either for drug covalent immobilization or
for additional modifications to modulate the polymer’s
properties. For instance, we can picture the covalent
immobilization an aminated drug by condensation of its
amino group to the carboxylated chain of the polymer,
yielding an enzyme-labile amide bond. This can be easily
achieved through peptide coupling chemistry similar to
that described for covalent binding of the C-terminal car-
boxyl group of bioactive peptides to the chitosan’s amino
P. Gomes et al. / Carbohydrate Polymers 71 (2008) 54–65 63groups (Hojo et al., 1999). Such polymer-drug conjugate
can work as a system for drug transport and delivery
in vivo that potentially: (i) protects the drug from meta-
bolic inactivation, (ii) protects the patient from the drug’s
secondary effects and (iii) allows for controlled drug
release through enzymatic hydrolysis of the drug–polymer
amide bond. Since this bond involves both the drug and a
proteinogenic a-amino acid from the PC polymer, it is
highly probable that it is recognized by proteases. On
the other hand, as enzymes have to reach the sites within
the polymer matrix at which the drug is attached, release
will most probably be slow. This is a picture that can be
drawn for virtually any drug that can be attached to our
peptide-chitosans through enzyme-labile bonds, given that
the polymers are ‘‘water-friendly’’ and porous enough to
allow the enzyme to enter and play its role. The new pep-
tide-chitosans herein reported also have the right proper-
ties to ensure this, as they are significantly less ordered
and more porous than the parent chitosan, as shown by
the thermotropic (DSC) and morphological (SEM) studies
carried out. This higher disorder leads to the higher sur-
face area and water-holding capacity that characterizes
these materials, more pronouncedly in the case of the
Asp-derived polymer, and will probably have a key role
in their performance as biocompatible and biodegradable
hydrogels for drug transport and controlled release
in vivo.
5. Conclusion
Our main objective was to surpass the obstacles related
to chitosan’s limited solubility. With this goal in mind, we
have successfully prepared carboxylated chitosan deriva-
tives through covalent binding of N-(3-bromopropanoyl)-
amino acid (peptide) ligands to the polymer’s primary
amino groups. The new polymers were obtained with DS
values around 30%, except in the case of the Phe-derived
polymer, and thus possess reduced net positive charge as
compared to the parent chitosan. This provided the new
peptide-chitosans with full water-solubility over practically
the entire physiological pH range and led to more disor-
dered and porous structures, with higher surface area
and water-holding capacity. Globally, the new peptide-
chitosans, and especially the Asp-derived polymer, possess
physico-chemical properties that turn them into promising
candidates as novel chitosan-based drug delivery
systems.
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